Related Experiment Video

Updated: Jun 17, 2026

A Preterm Rat Model for Pain Studies
01:37

A Preterm Rat Model for Pain Studies

Published on: February 9, 2024

Effects of pain management on sleep in preterm infants

Anna Axelin1, Jarkko Kirjavainen, Sanna Salanterä

  • 1Department of Nursing Science, Finnish Post-Graduate School in Nursing Science, University of Turku, Finland. anna.axelin@utu.fi

European Journal of Pain (London, England)
|December 19, 2009
PubMed

Insights

Pain management in preterm infants significantly alters sleep structure, with oxycodone drastically reducing REM sleep. This reduction in rapid eye movement (REM) sleep may impact brain development in vulnerable infants.

Area of Science:

  • Neonatal care
  • Pediatric sleep medicine
  • Pain management

Background:

  • Preterm infants experience prolonged pain and require effective pain management.
  • Understanding the impact of pain and its management on infant sleep is crucial for development.

Purpose of the Study:

  • To investigate the effects of different pain management strategies on the sleep structure of very preterm infants.
  • To compare the sleep architecture following painful procedures with and without pain management.

Main Methods:

  • A prospective, randomized, placebo-controlled, cross-over trial was conducted.
  • Polysomnography was used to record sleep structure in 18 preterm infants (28-32 weeks post-conceptional age).
  • Standardized nursing care with interventions (facilitated tucking by parents, oral glucose, oxycodone, or placebo) was administered at 3-hour intervals.

Main Results:

  • All interventions reduced rapid eye movement (REM) sleep in the first hour post-intervention.
  • Oxycodone significantly decreased REM sleep (48.0%) compared to oral glucose (64.4%), placebo (62.9%), and facilitated tucking by parents (61.6%).
  • Sleep onset occurred more frequently as non-rapid eye movement (NREM) sleep after oxycodone (50%) compared to other interventions.

Conclusions:

  • Oxycodone administration markedly alters the sleep structure in preterm infants, significantly reducing REM sleep.
  • The observed reduction in REM sleep following oxycodone may have implications for brain development in preterm infants.
Abstract

More Related Videos

Electrophysiological Measurements and Analysis of Nociception in Human Infants09:18

Electrophysiological Measurements and Analysis of Nociception in Human Infants

Published on: December 20, 2011

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares often...
Cause and Effect01:53

Cause and Effect

While variables are sometimes correlated because one does cause the other, it could also be that some other factor, a confounding variable, is actually causing the systematic movement in our variables of interest. For instance, as sales in ice cream increase, so does the overall rate of crime. Is it possible that indulging in your favorite flavor of ice cream could send you on a crime spree? Or, after committing crime do you think you might decide to treat yourself to a cone?